Disclosures for "Butyrophilin Peptides May Confer Tolerogenic Effects in MOG-immunized EAE Mice"
-
Ms. Jiang has nothing to disclose.
-
Dr. Bilodeau has nothing to disclose.
-
Mr. Murillo has nothing to disclose.
-
Miss Zhu has nothing to disclose.
-
Dr. Mikami has nothing to disclose.
-
Dr. Mahler has received research support from The Sumaira Foundation.
-
Dr. Nishiyama has nothing to disclose.
-
Dr. Anderson has nothing to disclose.
-
Dr. Bobrowski-Khoury has nothing to disclose.
-
Ms. Drosu has nothing to disclose.
-
Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Pharma. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Levy has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. The institution of Dr. Levy has received research support from National Institutes Health.